Actively Recruiting

Age: 0 - 18Years
All Genders
ID06309251

Clinical and Nutritional Effectiveness and Impact on the Quality of Life of the Ketogenic Diet in Pediatric Patients With Neurological, Genetic or Metabolic Disorders: a Multicenter Prospective Observational Study

Led by Danone Nutricia SpA Società Benefit · Updated on 2025-09-03

100

Participants Needed

3

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to learn about the clinical and nutritional effects of the ketogenic diet (KD) in children with genetic, neurological, or metabolic conditions that require this diet. The study focuses on whether KD supports proper growth, improves clinical symptoms, and impacts quality of life. It involves pediatric patients, including those with drug-resistant epilepsy and other neurological or metabolic diseases, to explore these areas more comprehensively. Participants receive a ketogenic diet as part of their clinical care. The specific prescription, type of KD protocol, and how it is administered depend on each child's ability to feed independently, their willingness, and the severity of their condition. This is an observational study, so treatments are given according to usual clinical practice, and the study follows patients over time to observe outcomes. During the study, participants will be monitored through regular clinical visits that assess nutritional adequacy, such as growth, lipid profiles, vitamin intake, and bone mineral density. Quality of life will be evaluated using parent questionnaires. The main outcome is nutritional adequacy measured at six months, with optional assessments at 12 months. Participants are followed as per normal clinical practice, with no experimental treatments assigned, allowing researchers to gather real-world information about KD's effects in this group.

CONDITIONS

Brief Title

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Who Can Participate

Age: 0 - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pediatric patients under 18 years with drug-resistant epilepsy (not responding to at least two antiseizure medications) treated with ketogenic diet
  • Pediatric patients under 18 years with metabolic, genetic, or neurological diseases treated with ketogenic diet, including new indications or ICU use for status epilepticus
Not Eligible

You will not qualify if you...

  • Patients with beta-oxidation cycle disorders, systemic primary carnitine deficiency, primary dyslipidemia, pyruvate carboxylase deficiency, porphyria, mitochondrial disease, ketone body metabolism defects, or gluconeogenesis defects
  • Children with type 1 diabetes
  • Parents or caregivers unable to guarantee adherence to the ketogenic diet treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - 6 months (12 months optional)

Participants who undergo routine ketogenic diet therapy as per clinical practice are observed for nutritional adequacy and health-related quality of life impacts.

Regular visits according to clinical practice

Trial Site Locations

Total: 3 locations

1

ASST Fatebenefratelli Sacco (PO "V. Buzzi")

Milan, MI, Italy, 20154

Actively Recruiting

2

Fondazione "Istituto Neurologico Nazionale C. Mondino"

Pavia, PV, Italy, 27100

Actively Recruiting

3

Ospedale Pediatrico Bambino Gesù

Roma, RM, Italy, 00165

Actively Recruiting

Loading map...

Research Team

A

Antonella Diamanti, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Center Based Early Intervention Program For Preschoolers W...

Development Disorder, Child

Actively Recruiting

1 location

A Chatbot-based Program to Promote Well-being in Caregivers ...

Autism Spectrum Disorder

Actively Recruiting

1 location

A Phase 3, Randomized, Double-blind, Placebo-controlled Clin...

Chronic Migraine

Actively Recruiting

108 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Anthropometric measurement standardization for a multicenter nutrition survey in children with spinal muscular atrophy.

Simona Bertoli, Andrea Foppiani, Ramona De Amicis...

https://pubmed.ncbi.nlm.nih.gov/30647441

Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Eric H Kossoff, Beth A Zupec-Kania, Stéphane Auvin...

https://pubmed.ncbi.nlm.nih.gov/29881797